A randomised, double-blind, placebo-controlled phase I clinical trial to evaluate the safety, tolerability and immunogenicity of three doses of an adjuvanted group B Streptococcus vaccine in older adults aged 55 to 75.
- DOI
- 10.1016/j.vaccine.2026.129133
- Published
- 2026 Sep 18
- Container
- Vaccine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.vaccine.2026.129133,
title = {A randomised, double-blind, placebo-controlled phase I clinical trial to evaluate the safety, tolerability and immunogenicity of three doses of an adjuvanted group B Streptococcus vaccine in older adults aged 55 to 75.},
author = {Oostvogels L and Alhatemi A and De Gussem S and Englev E and Fischer PB and Jacobs B and Johansson-Lindbom B and Kitson G and Waerlop G and Leroux-Roels I},
year = {2026},
journal = {Vaccine},
doi = {10.1016/j.vaccine.2026.129133},
url = {https://doi.org/10.1016/j.vaccine.2026.129133}
}RIS
TY - JOUR TI - A randomised, double-blind, placebo-controlled phase I clinical trial to evaluate the safety, tolerability and immunogenicity of three doses of an adjuvanted group B Streptococcus vaccine in older adults aged 55 to 75. AU - Oostvogels L AU - Alhatemi A AU - De Gussem S AU - Englev E AU - Fischer PB AU - Jacobs B AU - Johansson-Lindbom B AU - Kitson G AU - Waerlop G AU - Leroux-Roels I PY - 2026 JO - Vaccine DO - 10.1016/j.vaccine.2026.129133 UR - https://doi.org/10.1016/j.vaccine.2026.129133 ER -
APA
L, O., A, A., S, D. G., E, E., PB, F., B, J., B, J., G, K., G, W., & I, L. (2026). A randomised, double-blind, placebo-controlled phase I clinical trial to evaluate the safety, tolerability and immunogenicity of three doses of an adjuvanted group B Streptococcus vaccine in older adults aged 55 to 75.. Vaccine. https://doi.org/10.1016/j.vaccine.2026.129133
Source records
- pubmed · retrieved 2026-09-26T05:31:43.343Z